10-25 mg per day; Phase II/III clinical trials used 1-3 mg per day
Context: Dose figures reflect ranges commonly cited in performance/clinical literature and community reports, not a recommended protocol. This compound carries legal/controlled-substance status in many jurisdictions and is not approved for non-prescribed human use; entry is provided as a pharmacology reference only.
Formulation: Route-specific formulation and handling requirements apply.
Route safety: Reference range only. Do not treat as an individualized or clinically established protocol.
Source status: No direct community citation is attached to this amount.